European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-23

Praziquantel: its central role in the chemotherapy of schistosome infection

Cel

This proposal will be centred on aspects of praziquantel usage and will involve a group of scientists from disease endemic countries (with a major focus on Africa). They will be linked with a group of scientists from European Member States who share their common interest in researching the clinical, biological, epidemiological , pharmacological and socio-economic aspects of praziquantel use for the control of schistosome infection and disease. The Concerted Action will provide rational answers to questions related to the use of praziquantel in order to arm national health authorities and international agencies with appropriate information to ensure implementation of effective control programmes using praziquantel . The project will provide methodological tools to deal with any outbreak of drug resistant parasites and will develop strategies that if implemented will reduce the likelihood of emergence of drug resistant parasites

Program(-y)

Temat(-y)

Data not available

Zaproszenie do składania wniosków

Data not available

System finansowania

CON - Coordination of research actions

Koordynator

UNIVERSITY OF GLASGOW
Wkład UE
Brak danych
Adres
University Avenue, Joseph Black Building
G12 8QQ GLASGOW
Zjednoczone Królestwo

Zobacz na mapie
Koszt całkowity
Brak danych

Uczestnicy (20)

Udostępnij tę stronę

Pobierz

Ostatnia aktualizacja: 12 Kwietnia 2005

Moja broszura

Permalink: https://cordis.europa.eu/project/id/ICA4-CT-2002-10054/pl

European Union, 2024